A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

NCT00207766 ·Status: COMPLETED ·Phase: PHASE3

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT04673357 ·Status: COMPLETED ·Phase: PHASE3

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

NCT00207688 ·Status: COMPLETED

Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

NCT01752790 ·Status: WITHDRAWN ·Phase: PHASE4

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

NCT00096655 ·Status: COMPLETED ·Phase: PHASE3

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

NCT05906576 ·Status: RECRUITING ·Phase: PHASE4

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

NCT02772965 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

NCT03596645 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

NCT00606346 ·Status: ACTIVE_NOT_RECRUITING

Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience

NCT01490528 ·Status: UNKNOWN

A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease

NCT04312659 ·Status: COMPLETED

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT05442567 ·Status: RECRUITING ·Phase: PHASE3

Top-down Infliximab Study in Kids With Crohn's Disease

NCT02517684 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT05995353 ·Status: RECRUITING ·Phase: PHASE3

A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease

NCT03478956 ·Status: TERMINATED ·Phase: PHASE1

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

NCT02093663 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

NCT05057273 ·Status: WITHDRAWN ·Phase: PHASE2

Precise Infliximab Exposure and Pharmacodynamic Control

NCT05660746 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Combined Immunosuppression for Pediatric Crohn's Disease

NCT05043870 ·Status: RECRUITING ·Phase: PHASE4

Infliximab Top-down in Pediatric Crohn

NCT01880307 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

NCT00686374 ·Status: COMPLETED ·Phase: PHASE3

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

NCT02771457 ·Status: WITHDRAWN ·Phase: PHASE3

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03138655 ·Status: COMPLETED ·Phase: PHASE2